JCO: The impact of intensive drug intervention on the safety of new oral anticancer drugs and the prognosis reported by patients
Establish an artificial biosynthetic pathway for the anti-tumor drug candidate icariin
Cervical cancer market: Bio-similar drugs are on the rise, and vaccines differ significantly in domestic and foreign patterns
Shandong sampling: 24 batches of unqualified foods have serious problems with excessive pesticide and veterinary drug residues
Xenotransplantation, the root cause of the ineffectiveness of some cancer drugs
The European Union approves the anti-epileptic drug Ontozry (cenobamate)
Significant progress in the study of drug-resistant plasmids
Lancet Oncol: The correlation between various antihypertensive drugs and cancer risk
BeiGene Guangzhou Biopharmaceutical Production Base was officially opened, allowing Chinese patients to enjoy international-quality anticancer drugs
National Health Commission issued a document: Further strengthen the management of antimicrobial drugs
New crown research: an antiparasitic drug may prevent lung cell fusion
Hypertension: The relationship between the types of antihypertensive drugs and cardiovascular outcomes in HIV-infected hypertensive patients
iPS cells are used for COVID-19 drug screening
The second batch of key monitoring, key attention drug list release
Zhengda Tianqing, Qilu, Hausen... Siege 700 million anti-tumor drugs!
Tojo Pharmaceuticals: In-depth layout of the development and commercialization of anti-tumor ADC drugs
Antibody-conjugated drugs (ADC) have both the cytotoxicity of small molecules and the targeting properties
Siddi Medicine obtains the exclusive authorization of the new generation of CD47 antibody drug in Greater China
On March 31, 2021, Sidi Medicine, located in the Shanghai International Medical Park of Zhangjiang Science City
A batch of drugs were investigated: Fengre Ganmao Granules, Ganmaoling Granules...
The first imitation of Haisco's anti-ED drug is approved, and the blockbuster injection will start phase III clinical trials
Recently, high scores have been reported frequently by Haisco.
On March 29, two consecutive product announcements
The leader changed hands, and the innovative drug "God Assist" Hengrui became the king!